Hi KTM, yep an excellent result. On the underwriting fee, do they get that on the total that they may have had to commit, ie $4m odd or only on what they actually commit, ie the $420k. Thanks
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
